Related Experiment Video

Updated: Jun 29, 2025

Imaging Glioma Initiation In Vivo Through a Polished and Reinforced Thin-skull Cranial Window
09:44

Imaging Glioma Initiation In Vivo Through a Polished and Reinforced Thin-skull Cranial Window

Published on: November 20, 2012

13.1K

INDIGO: Example of inappropriate crossover and why PFS cannot be the primary outcome in gliomas

Miguel Zugman1, Alyson Haslam2, Vinay Prasad3

  • 1Centro de Oncologia e Hematologia Einstein Família Dayan-Daycoval, Hospital Israelita Albert Einstein, São Paulo, Brazil.

Journal of Cancer Policy
|April 8, 2024
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Primary Orthotopic Glioma Xenografts Recapitulate Infiltrative Growth and Isocitrate Dehydrogenase I Mutation
09:43

Primary Orthotopic Glioma Xenografts Recapitulate Infiltrative Growth and Isocitrate Dehydrogenase I Mutation

Published on: January 14, 2014

8.1K
Author Spotlight: Enhanced Generation of Patient-Derived 3D Organoids for Glioblastoma and Glioma
05:45

Author Spotlight: Enhanced Generation of Patient-Derived 3D Organoids for Glioblastoma and Glioma

Published on: January 19, 2024

1.8K

Related Experiment Videos

Last Updated: Jun 29, 2025

Imaging Glioma Initiation In Vivo Through a Polished and Reinforced Thin-skull Cranial Window
09:44

Imaging Glioma Initiation In Vivo Through a Polished and Reinforced Thin-skull Cranial Window

Published on: November 20, 2012

13.1K
Primary Orthotopic Glioma Xenografts Recapitulate Infiltrative Growth and Isocitrate Dehydrogenase I Mutation
09:43

Primary Orthotopic Glioma Xenografts Recapitulate Infiltrative Growth and Isocitrate Dehydrogenase I Mutation

Published on: January 14, 2014

8.1K
Author Spotlight: Enhanced Generation of Patient-Derived 3D Organoids for Glioblastoma and Glioma
05:45

Author Spotlight: Enhanced Generation of Patient-Derived 3D Organoids for Glioblastoma and Glioma

Published on: January 19, 2024

1.8K

Related Concept Videos

Tumor Progression02:07

Tumor Progression

6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

135
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
135

Articles linked to this work by shared authors, journal, and citation graph.

Regional Variation in Bladder Cancer Clinical Trial Availability in the US.

JAMA network open·2026

Real-World Efficacy and Safety of Belzutifan in Sporadic Metastatic Renal Cell Carcinoma.

Clinical genitourinary cancer·2026

Evaluating Global Disparities in the Availability of Prostate Cancer Clinical Trials.

JCO global oncology·2026

Assessing Geographic Disparities in the Availability of Renal Cell Carcinoma Clinical Trials in the United States.

JCO oncology practice·2026

Genomic Characterization of Urothelial Carcinoma and Sarcomatoid Carcinoma of the Upper Urinary Tract.

Cancers·2026

Real-world genomic profiling of solid tumors: validation and clinical insights from a Brazilian cohort.

Einstein (Sao Paulo, Brazil)·2026

Process evaluation of a national initiative to detect cancer early in Scotland.

Journal of cancer policy·2026

Availability and affordability of essential anticancer medicines in a resource-constrained province of Iran: A WHO/HAI-based public health assessment.

Journal of cancer policy·2026

Workforce stratification as a cancer research equity and capacity intervention: A policy and implementation framework for oncology clinical trial sites.

Journal of cancer policy·2026

Catastrophic out-of-pocket healthcare expenditures among cancer patients receiving systemic therapy and/or radiation therapy in Bangladesh.

Journal of cancer policy·2026

Geographic disparities, trial characteristics, and transparency of 3720 ovarian cancer clinical trials.

Journal of cancer policy·2026

Early implementation of radiofrequency ablation for breast cancer in Japan: What national claims data reveal and obscure.

Journal of cancer policy·2026

Non-coding RNAs in cancer: multi-omics insights, liquid biopsy advances, drug resistance mechanisms, and the road to clinical translation.

Frontiers in oncology·2026

Case Report: Occult mantle cell lymphoma in a synchronous rectal collision tumor with adenocarcinoma: retrospective reclassification and multispecimen molecular profiling.

Frontiers in oncology·2026

Undifferentiated round cell sarcoma with CIC::NUTM1 fusion: expanding the clinicopathologic spectrum of a rare molecular variant of CIC-rearranged sarcoma.

Virchows Archiv : an international journal of pathology·2026

Case Report: Hidden danger in breast eczematous lesions: cutaneous metastasis from silent lung adenocarcinoma misdiagnosed as Paget's disease.

Frontiers in oncology·2026

Primary adenoid cystic carcinoma of the breast: a clinicopathological case series.

Korean journal of clinical oncology·2026

Unnatural definitions for natural experiments: a call for clarity when estimating causal effects of interventions.

Journal of epidemiology and community health·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us